Skip to main content
Erschienen in: Archives of Virology 1/2018

11.10.2017 | Original Article

Association of interferon lambda polymorphisms with elevated baseline viral loads in chronic hepatitis C virus genotype 6 infection

verfasst von: Linh Thuy Nguyen, Dzung Van Nguyen, Michael J. Carr, William W. Hall, Lan Anh Nguyen

Erschienen in: Archives of Virology | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Globally, hepatitis C virus (HCV) is one of the major causes of hepatocellular carcinoma and liver cirrhosis. For clinical decision making, genetic variation in the interferon-λ (IFNL) cluster has been utilised as a baseline predictor of natural and interferon-based treatment-induced viral clearance. In Vietnam, where HCV genotypes 1 (g1) and g6 predominate, no prior studies have been conducted investigating associations of IFNL3/4 polymorphisms with spontaneous clearance (SC) or HCV viral load (VL) in chronic infection. In this study, we have investigated the host genetic variations in IFNL loci to determine the association of IFNL3/4 polymorphisms with HCV SC and baseline VLs in a Vietnamese HCV-seropositive cohort. The majority of the cohort harboured major homozygous polymorphisms in IFNL3/4 cluster (i.e. rs12979860-CC: 82.7%; rs8099917-TT: 84.8% and rs368234815-TT/TT: 85.5%) and the SC rates in these groups were 15.8%, 16.3% and 15.7%, respectively. In the minor allele groups, the resolution rates were lower (12% in rs12979860 non-CC, 9.1% in rs8099917 non-TT and 9.5% in rs368234815 non-TT/TT). Furthermore, in individuals harbouring minor alleles, females achieved higher SC rates than males. HCV g6-infected rs12979860 major homozygous individuals had significantly higher viral loads than individuals with minor alleles (CC: 6.56 log IU/ml vs. non-CC: 5.66 log IU/ml; P = 0.021). The association between IFNL3/4 genotypes with elevated HCV VL observed in HCV g6-infected individuals may have implications for the progression of liver disease in Southeast Asian countries where this viral genotype predominates and therefore warrants further studies.
Literatur
1.
2.
Zurück zum Zitat Hajarizadeh B, Grebely J, Dore GJ (2013) Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol 10:553–562CrossRefPubMed Hajarizadeh B, Grebely J, Dore GJ (2013) Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol 10:553–562CrossRefPubMed
3.
Zurück zum Zitat Micallef JM, Kaldor JM, Dore GJ (2006) Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat 13:34–41CrossRefPubMed Micallef JM, Kaldor JM, Dore GJ (2006) Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat 13:34–41CrossRefPubMed
4.
Zurück zum Zitat Ge D, Fellay J, Thompson AJ et al (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461:399–401CrossRefPubMed Ge D, Fellay J, Thompson AJ et al (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461:399–401CrossRefPubMed
5.
Zurück zum Zitat Tanaka Y, Nishida N, Sugiyama M et al (2009) Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 41:1105–1109CrossRefPubMed Tanaka Y, Nishida N, Sugiyama M et al (2009) Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 41:1105–1109CrossRefPubMed
6.
Zurück zum Zitat Rauch A, Kutalik Z, Descombes P et al (2010) Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 138:1338–1345 (1345.e1331-1337) CrossRefPubMed Rauch A, Kutalik Z, Descombes P et al (2010) Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 138:1338–1345 (1345.e1331-1337) CrossRefPubMed
7.
Zurück zum Zitat Matsuura K, Watanabe T, Tanaka Y (2014) Role of IL28B for chronic hepatitis C treatment toward personalized medicine. J Gastroenterol Hepatol 29:241–249CrossRefPubMed Matsuura K, Watanabe T, Tanaka Y (2014) Role of IL28B for chronic hepatitis C treatment toward personalized medicine. J Gastroenterol Hepatol 29:241–249CrossRefPubMed
8.
Zurück zum Zitat Nguyen LT, Gray E, Dean J et al (2015) Baseline prevalence and emergence of protease inhibitor resistance mutations following treatment in chronic HCV genotype-1-infected individuals. Antivir Ther 20:865–869CrossRefPubMed Nguyen LT, Gray E, Dean J et al (2015) Baseline prevalence and emergence of protease inhibitor resistance mutations following treatment in chronic HCV genotype-1-infected individuals. Antivir Ther 20:865–869CrossRefPubMed
9.
10.
Zurück zum Zitat Shebl FM, Pfeiffer RM, Buckett D et al (2011) IL28B rs12979860 genotype and spontaneous clearance of hepatitis C virus in a multi-ethnic cohort of injection drug users: evidence for a supra-additive association. J Infect Dis 204:1843–1847CrossRefPubMedPubMedCentral Shebl FM, Pfeiffer RM, Buckett D et al (2011) IL28B rs12979860 genotype and spontaneous clearance of hepatitis C virus in a multi-ethnic cohort of injection drug users: evidence for a supra-additive association. J Infect Dis 204:1843–1847CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat EASL (2014) EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol 60:392–420CrossRef EASL (2014) EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol 60:392–420CrossRef
12.
Zurück zum Zitat Prokunina-Olsson L, Muchmore B, Tang W et al (2013) A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet 45:164–171CrossRefPubMedPubMedCentral Prokunina-Olsson L, Muchmore B, Tang W et al (2013) A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet 45:164–171CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Dunford L, Carr MJ, Dean J et al (2012) Hepatitis C virus in Vietnam: high prevalence of infection in dialysis and multi-transfused patients involving diverse and novel virus variants. PLoS One 7:e41266CrossRefPubMedPubMedCentral Dunford L, Carr MJ, Dean J et al (2012) Hepatitis C virus in Vietnam: high prevalence of infection in dialysis and multi-transfused patients involving diverse and novel virus variants. PLoS One 7:e41266CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Wasitthankasem R, Vongpunsawad S, Siripon N et al (2015) Genotypic distribution of hepatitis C virus in Thailand and southeast Asia. PLoS One 10:e0126764CrossRefPubMedPubMedCentral Wasitthankasem R, Vongpunsawad S, Siripon N et al (2015) Genotypic distribution of hepatitis C virus in Thailand and southeast Asia. PLoS One 10:e0126764CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Daniel HD, Grant PR, Garson JA, Tedder RS, Chandy GM, Abraham P (2008) Quantitation of hepatitis C virus using an in-house real-time reverse transcriptase polymerase chain reaction in plasma samples. Diagn Microbiol Infect Dis 61:415–420CrossRefPubMed Daniel HD, Grant PR, Garson JA, Tedder RS, Chandy GM, Abraham P (2008) Quantitation of hepatitis C virus using an in-house real-time reverse transcriptase polymerase chain reaction in plasma samples. Diagn Microbiol Infect Dis 61:415–420CrossRefPubMed
16.
Zurück zum Zitat Pybus OG, Barnes E, Taggart R et al (2009) Genetic history of hepatitis C virus in East Asia. J Virol 83:1071–1082CrossRefPubMed Pybus OG, Barnes E, Taggart R et al (2009) Genetic history of hepatitis C virus in East Asia. J Virol 83:1071–1082CrossRefPubMed
17.
Zurück zum Zitat Kalaghatgi P, Sikorski AM, Knops E et al (2016) Geno2pheno[HCV]—a web-based interpretation system to support hepatitis C treatment decisions in the era of direct-acting antiviral agents. PLoS One 11:e0155869CrossRefPubMedPubMedCentral Kalaghatgi P, Sikorski AM, Knops E et al (2016) Geno2pheno[HCV]—a web-based interpretation system to support hepatitis C treatment decisions in the era of direct-acting antiviral agents. PLoS One 11:e0155869CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Collison M, Chin JL, Abu Shanab A et al (2015) Homozygosity for HLA group 2 alleles predicts treatment failure with interferon-alpha and ribavirin in chronic hepatitis C virus genotype 1 infection. J Interferon Cytokine Res 35:126–133CrossRefPubMed Collison M, Chin JL, Abu Shanab A et al (2015) Homozygosity for HLA group 2 alleles predicts treatment failure with interferon-alpha and ribavirin in chronic hepatitis C virus genotype 1 infection. J Interferon Cytokine Res 35:126–133CrossRefPubMed
19.
Zurück zum Zitat Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H (2014) Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 61:S45–S57CrossRefPubMed Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H (2014) Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 61:S45–S57CrossRefPubMed
20.
Zurück zum Zitat Schinazi R, Halfon P, Marcellin P, Asselah T (2014) HCV direct-acting antiviral agents: the best interferon-free combinations. Liver Int 34(Suppl 1):69–78CrossRefPubMed Schinazi R, Halfon P, Marcellin P, Asselah T (2014) HCV direct-acting antiviral agents: the best interferon-free combinations. Liver Int 34(Suppl 1):69–78CrossRefPubMed
21.
Zurück zum Zitat Grebely J, Page K, Sacks-Davis R et al (2014) The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology 59:109–120CrossRefPubMed Grebely J, Page K, Sacks-Davis R et al (2014) The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology 59:109–120CrossRefPubMed
22.
Zurück zum Zitat Watanabe H, Saito T, Shinzawa H et al (2003) Spontaneous elimination of serum hepatitis C virus (HCV) RNA in chronic HCV carriers: a population-based cohort study. J Med Virol 71:56–61CrossRefPubMed Watanabe H, Saito T, Shinzawa H et al (2003) Spontaneous elimination of serum hepatitis C virus (HCV) RNA in chronic HCV carriers: a population-based cohort study. J Med Virol 71:56–61CrossRefPubMed
23.
Zurück zum Zitat Scott JD, McMahon BJ, Bruden D et al (2006) High rate of spontaneous negativity for hepatitis C virus RNA after establishment of chronic infection in Alaska Natives. Clin Infect Dis 42:945–952CrossRefPubMed Scott JD, McMahon BJ, Bruden D et al (2006) High rate of spontaneous negativity for hepatitis C virus RNA after establishment of chronic infection in Alaska Natives. Clin Infect Dis 42:945–952CrossRefPubMed
24.
Zurück zum Zitat Bulteel N, Partha Sarathy P, Forrest E et al (2016) Factors associated with spontaneous clearance of chronic hepatitis C virus infection. J Hepatol 65:266–272CrossRefPubMed Bulteel N, Partha Sarathy P, Forrest E et al (2016) Factors associated with spontaneous clearance of chronic hepatitis C virus infection. J Hepatol 65:266–272CrossRefPubMed
25.
Zurück zum Zitat Thong VD, Wasitthankasem R, Tangkijvanich P, Vongpunsawad S, Poovorawan Y (2015) Prevalence of thymine-adenine dinucleotide repeat, IL28B and IFNL4 in thai population and correlation with spontaneous clearance and treatment outcome of hepatitis C infection. PLoS One 10:e0125400CrossRefPubMedPubMedCentral Thong VD, Wasitthankasem R, Tangkijvanich P, Vongpunsawad S, Poovorawan Y (2015) Prevalence of thymine-adenine dinucleotide repeat, IL28B and IFNL4 in thai population and correlation with spontaneous clearance and treatment outcome of hepatitis C infection. PLoS One 10:e0125400CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Rao HY, Sun DG, Jiang D et al (2012) IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection. J Viral Hepat 19:173–181CrossRefPubMed Rao HY, Sun DG, Jiang D et al (2012) IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection. J Viral Hepat 19:173–181CrossRefPubMed
27.
Zurück zum Zitat Lee MH, Yang HI, Lu SN et al (2015) Polymorphisms near the IFNL3 gene associated with HCV RNA spontaneous clearance and hepatocellular carcinoma risk. Sci Rep 5:17030CrossRefPubMedPubMedCentral Lee MH, Yang HI, Lu SN et al (2015) Polymorphisms near the IFNL3 gene associated with HCV RNA spontaneous clearance and hepatocellular carcinoma risk. Sci Rep 5:17030CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Ikezaki H, Furusyo N, Hiramine S et al (2016) Association of IL28B rs8099917 genotype and female sex with spontaneous clearance of hepatitis C virus infection: a Japanese cross-sectional study. Arch Virol 161:641–648CrossRefPubMed Ikezaki H, Furusyo N, Hiramine S et al (2016) Association of IL28B rs8099917 genotype and female sex with spontaneous clearance of hepatitis C virus infection: a Japanese cross-sectional study. Arch Virol 161:641–648CrossRefPubMed
29.
Zurück zum Zitat Heim MH, Bochud PY, George J (2016) Host—hepatitis C viral interactions: the role of genetics. J Hepatol 65:S22–S32CrossRefPubMed Heim MH, Bochud PY, George J (2016) Host—hepatitis C viral interactions: the role of genetics. J Hepatol 65:S22–S32CrossRefPubMed
30.
Zurück zum Zitat Duggal P, Thio CL, Wojcik GL et al (2013) Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med 158:235–245CrossRefPubMedPubMedCentral Duggal P, Thio CL, Wojcik GL et al (2013) Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med 158:235–245CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Xu Y, Huang P, Yue M et al (2016) A novel polymorphism near HLA class II region is associated with spontaneous clearance of HCV and response to interferon treatment in Chinese patients. J Hum Genet 61:301–305CrossRefPubMed Xu Y, Huang P, Yue M et al (2016) A novel polymorphism near HLA class II region is associated with spontaneous clearance of HCV and response to interferon treatment in Chinese patients. J Hum Genet 61:301–305CrossRefPubMed
32.
Zurück zum Zitat Hajarizadeh B, Grady B, Page K et al (2014) Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: the InC(3) study. J Clin Virol 61:430–434CrossRefPubMedPubMedCentral Hajarizadeh B, Grady B, Page K et al (2014) Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: the InC(3) study. J Clin Virol 61:430–434CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Liu L, Fisher BE, Thomas DL, Cox AL, Ray SC (2012) Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution. Hepatology 55:1684–1691CrossRefPubMedPubMedCentral Liu L, Fisher BE, Thomas DL, Cox AL, Ray SC (2012) Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution. Hepatology 55:1684–1691CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Grady BP, Prins M, Rebers S, Molenkamp R, Geskus RB, Schinkel J (2015) BMI, male sex and IL28B genotype associated with persistently high hepatitis C virus RNA levels among chronically infected drug users up to 23 years following seroconversion. J Viral Hepat 22:263–271CrossRefPubMed Grady BP, Prins M, Rebers S, Molenkamp R, Geskus RB, Schinkel J (2015) BMI, male sex and IL28B genotype associated with persistently high hepatitis C virus RNA levels among chronically infected drug users up to 23 years following seroconversion. J Viral Hepat 22:263–271CrossRefPubMed
35.
Zurück zum Zitat Bucci C, von Delft A, Christian A et al (2013) ‘Favourable’ IL28B polymorphisms are associated with a marked increase in baseline viral load in hepatitis C virus subtype 3a infection and do not predict a sustained virological response after 24 weeks of therapy. J Gen Virol 94:1259–1265CrossRefPubMed Bucci C, von Delft A, Christian A et al (2013) ‘Favourable’ IL28B polymorphisms are associated with a marked increase in baseline viral load in hepatitis C virus subtype 3a infection and do not predict a sustained virological response after 24 weeks of therapy. J Gen Virol 94:1259–1265CrossRefPubMed
36.
Zurück zum Zitat Hajarizadeh B, Grady B, Page K et al (2015) Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC3 study. J Viral Hepat 22:708–717CrossRefPubMedPubMedCentral Hajarizadeh B, Grady B, Page K et al (2015) Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC3 study. J Viral Hepat 22:708–717CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Uccellini L, Tseng FC, Monaco A et al (2012) HCV RNA levels in a multiethnic cohort of injection drug users: human genetic, viral and demographic associations. Hepatology 56:86–94CrossRefPubMedPubMedCentral Uccellini L, Tseng FC, Monaco A et al (2012) HCV RNA levels in a multiethnic cohort of injection drug users: human genetic, viral and demographic associations. Hepatology 56:86–94CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Abdelwahab SF, Zakaria Z, Allam WR et al (2015) Interleukin 28B.rs12979860 genotype does not affect hepatitis C viral load in Egyptians with genotype 4 chronic infection. Arch Virol 160:2833–2837CrossRefPubMed Abdelwahab SF, Zakaria Z, Allam WR et al (2015) Interleukin 28B.rs12979860 genotype does not affect hepatitis C viral load in Egyptians with genotype 4 chronic infection. Arch Virol 160:2833–2837CrossRefPubMed
39.
Zurück zum Zitat Messina J, Humphreys I, Flaxman A et al (2015) Global distribution and prevalence of hepatitis C virus genotypes. Hapatology 61:77–87CrossRef Messina J, Humphreys I, Flaxman A et al (2015) Global distribution and prevalence of hepatitis C virus genotypes. Hapatology 61:77–87CrossRef
40.
Zurück zum Zitat Noureddin M, Wright EC, Alter HJ et al (2013) Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis. Hepatology 58:1548–1557CrossRefPubMedPubMedCentral Noureddin M, Wright EC, Alter HJ et al (2013) Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis. Hepatology 58:1548–1557CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Grebely J, Grady B, Hajarizadeh B, Page K, Dore GJ, Group INCS (2014) Disease progression during advanced fibrosis: IL28B genotype or HCV RNA levels? Hepatology 59:1650–1651CrossRefPubMedPubMedCentral Grebely J, Grady B, Hajarizadeh B, Page K, Dore GJ, Group INCS (2014) Disease progression during advanced fibrosis: IL28B genotype or HCV RNA levels? Hepatology 59:1650–1651CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Ishiguro S, Inoue M, Tanaka Y, Mizokami M, Iwasaki M, Tsugane S (2011) Impact of viral load of hepatitis C on the incidence of hepatocellular carcinoma: a population-based cohort study (JPHC Study). Cancer Lett 300:173–179CrossRefPubMed Ishiguro S, Inoue M, Tanaka Y, Mizokami M, Iwasaki M, Tsugane S (2011) Impact of viral load of hepatitis C on the incidence of hepatocellular carcinoma: a population-based cohort study (JPHC Study). Cancer Lett 300:173–179CrossRefPubMed
43.
Metadaten
Titel
Association of interferon lambda polymorphisms with elevated baseline viral loads in chronic hepatitis C virus genotype 6 infection
verfasst von
Linh Thuy Nguyen
Dzung Van Nguyen
Michael J. Carr
William W. Hall
Lan Anh Nguyen
Publikationsdatum
11.10.2017
Verlag
Springer Vienna
Erschienen in
Archives of Virology / Ausgabe 1/2018
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-017-3583-y

Weitere Artikel der Ausgabe 1/2018

Archives of Virology 1/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.